Your browser doesn't support javascript.
loading
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors.
Chan, Stephen L; Schuler, Martin; Kang, Yoon-Koo; Yen, Chia-Jui; Edeline, Julien; Choo, Su Pin; Lin, Chia-Chi; Okusaka, Takuji; Weiss, Karl-Heinz; Macarulla, Teresa; Cattan, Stéphane; Blanc, Jean-Frederic; Lee, Kyung-Hun; Maur, Michela; Pant, Shubham; Kudo, Masatoshi; Assenat, Eric; Zhu, Andrew X; Yau, Thomas; Lim, Ho Yeong; Bruix, Jordi; Geier, Andreas; Guillén-Ponce, Carmen; Fasolo, Angelica; Finn, Richard S; Fan, Jia; Vogel, Arndt; Qin, Shukui; Riester, Markus; Katsanou, Vasiliki; Chaudhari, Monica; Kakizume, Tomoyuki; Gu, Yi; Porta, Diana Graus; Myers, Andrea; Delord, Jean-Pierre.
Afiliação
  • Chan SL; State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Sir YK Pao Centre for Cancer, The Chinese University of Hong Kong, Hong Kong, China. chanlam_stephen@cuhk.edu.hk.
  • Schuler M; West German Cancer Center, University Hospital Essen, Germany & German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany.
  • Kang YK; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Yen CJ; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Edeline J; Centre Eugène Marquis, Rennes, France and ARPEGO (Accès à La Recherche Précoce Dans Le Grand-Ouest) Network, Rennes, France.
  • Choo SP; National Cancer Centre, Singapore, Singapore.
  • Lin CC; National Taiwan University Hospital, Taipei, Taiwan.
  • Okusaka T; National Cancer Centre Hospital, Tokyo, Japan.
  • Weiss KH; Salem Medical Center, Internal Medicine, Heidelberg, Germany.
  • Macarulla T; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), IOB Quirón, Barcelona, Spain.
  • Cattan S; Chru de Lille, Lille, France.
  • Blanc JF; CHU de Bordeaux Pessac, Bordeaux, France.
  • Lee KH; Seoul National University Hospital, Seoul, South Korea.
  • Maur M; University Hospital of Modena, Modena, Italy.
  • Pant S; MD Anderson Cancer Center, Houston, TX, USA.
  • Kudo M; Kindai University Hospital, Osaka, Japan.
  • Assenat E; Hôpital Saint-Eloi Montpellier, Montpellier, France.
  • Zhu AX; Massachusetts General Hospital, Boston, MA, USA.
  • Yau T; Jiahui International Cancer Center, Jiahui Health, Shanghai, China.
  • Lim HY; Queen Mary Hospital, Hong Kong, China.
  • Bruix J; Samsung Medical Center, Seoul, South Korea.
  • Geier A; Barcelona clinic liver cancer (BCLC) Group, Liver Unit, Hospital Clínic, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain.
  • Guillén-Ponce C; University Hospital Würzburg, Würzburg, Germany.
  • Fasolo A; Hospital Universitario Ramon y Cajal, IRYCIS, Madrid, Spain.
  • Finn RS; San Raffaele Hospital, Milan, Italy.
  • Fan J; University of California, Los Angeles, California, USA.
  • Vogel A; Zhongshan Hospital, Fudan University, Shanghai, China.
  • Qin S; Hannover Medical School, Hanover, Germany.
  • Riester M; No. 81th PLA Hospital Nanjing, Jiangsu, China.
  • Katsanou V; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Chaudhari M; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Kakizume T; IQVIA, Durham, North Carolina, USA.
  • Gu Y; Novartis Pharma K.K, Tokyo, Japan.
  • Porta DG; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Myers A; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Delord JP; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
J Exp Clin Cancer Res ; 41(1): 189, 2022 Jun 02.
Article em En | MEDLINE | ID: mdl-35655320
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2022 Tipo de documento: Article